Bristol Myers buys Nvidia’s latest AI computing system for drug research
By Michael Erman NEW YORK, July 20 (Reuters) – Bristol Myers Squibb said on Monday it is buying…
How Is Pfizer’s Stock Performance Compared to Other Healthcare Stocks?
With a market cap of $149.2 billion, Pfizer Inc. (PFE) is a global biopharmaceutical company that discovers, develops, manufactures,…
Thinning revenues: inside the $14bn Eliquis patent cliff
Eliquis (apixaban) is one of the most commercially consequential loss-of-exclusivity (LOE) events in recent pharmaceutical history, with patent…
Eliquis proves safer than Xarelto for patients with deep blood clots
March 13 (Reuters) – A trial directly comparing Eliquis and Xarelto – two commonly used blood-thinning drugs from…
3 Healthcare Stocks Paying the Highest Dividends of 2026
Could your portfolio use some more exposure to the healthcare sector as well as more income? If so,…
Medication cost prevents cancer patient from accessing treatment
GOSNELL, Ark. (KAIT) – Jen Holifield has multiple myeloma, an incurable blood cancer. Her doctor prescribed Lenalidomide —…
FDA accepts BMS protein degrader for review; Disc rare disease drug rejected
This story was originally published on BioPharma Dive. To receive daily news and insights, subscribe to our free…
Nektar, continuing comeback, says eczema drug’s effects hold up in follow-up study
This story was originally published on BioPharma Dive. To receive daily news and insights, subscribe to our free…
Got $500? 3 Dividend-Paying Healthcare Stocks to Buy and Hold Forever
Bristol Myers Squibb is a pharmaceutical giant with a solid dividend history. Medtronic is a high-yield medical device…
Got $1,000? 2 High-Yield Healthcare Stocks to Buy and Hold Forever
This drug company offers a decent balance of risk and reward, with a 4.6% yield and a payout…
Do These 3 Healthcare Stocks Need a Checkup?
Pfizer has a sizable 6.8% yield and is down nearly 60% from its 2021 highs. Bristol Myers Squibb…
Radiopharmaceuticals Market to Reach US$ 13.4 Billion by 2033
AstuteAnalytica India Pvt. Ltd. Surging multibillion dollar acquisitions and a pipeline of innovative therapies define the current landscape.…